Christiane Steinert1, Mareike Hofmann2, Johannes Kruse3, Falk Leichsenring2. 1. Clinic for Psychosomatic Medicine and Psychotherapy, University of Giessen, Ludwigstrasse 76, 35392 Giessen, Germany. Electronic address: christiane.steinert@psycho.med.uni-giessen.de. 2. Clinic for Psychosomatic Medicine and Psychotherapy, University of Giessen, Ludwigstrasse 76, 35392 Giessen, Germany. 3. Clinic for Psychosomatic Medicine and Psychotherapy, University of Giessen, Ludwigstrasse 76, 35392 Giessen, Germany; Clinic for Psychosomatic Medicine and Psychotherapy, University of Marburg, Germany.
Abstract
BACKGROUND: Depression is the most common mental disorder. Effective psychotherapeutic treatments for depression exist; however, data on their long-term effectiveness beyond a time span of two years is still scarce. Our aim was to perform a meta-analysis, investigating (a) overall rates of relapse more than two years after psychotherapy (meta-analysis 1), and (b) if psychotherapy has more enduring effects than non-psychotherapeutic comparison conditions (e.g. pharmacotherapy, treatment as usual), again beyond a time span of two years post-therapy (meta-analysis 2). METHODS: We searched electronic databases Medline, PsycINFO and the COCHRANE Library. Main selection criteria were (i) RCT of psychotherapy with follow-up interval of more than 2 years, (ii) primary diagnosis of depression, assessed by observer ratings, (iii) report of relapse at follow-up. RESULTS: We identified 11 studies, 6 of which included a non-psychotherapeutic comparison condition. Together they comprised long-term data of 966 patients. Mean follow-up duration was 4.4 years. The overall relapse rate at long-term follow-up was 0.39 (95% CI 0.29, 0.50). Psychotherapy resulted in significantly less relapses (53.1% vs. 71.1%, OR 0.51; 95% CI 0.32, 0.82, p=0.005) than comparison treatments. This finding corresponded to a number needed to treat (NNT) of 5.55. LIMITATIONS: Results can only be preliminary as data was sparse and studies differed methodologically. Heterogeneity in the first meta-analysis was high (I(2)=82%). Results indicated publication bias. CONCLUSIONS: The relapse rate more than two years after psychotherapy is relatively high, but significantly lower compared to non-psychotherapeutic treatments. Multiannual follow-ups should routinely be included in future psychotherapy RCTs.
BACKGROUND:Depression is the most common mental disorder. Effective psychotherapeutic treatments for depression exist; however, data on their long-term effectiveness beyond a time span of two years is still scarce. Our aim was to perform a meta-analysis, investigating (a) overall rates of relapse more than two years after psychotherapy (meta-analysis 1), and (b) if psychotherapy has more enduring effects than non-psychotherapeutic comparison conditions (e.g. pharmacotherapy, treatment as usual), again beyond a time span of two years post-therapy (meta-analysis 2). METHODS: We searched electronic databases Medline, PsycINFO and the COCHRANE Library. Main selection criteria were (i) RCT of psychotherapy with follow-up interval of more than 2 years, (ii) primary diagnosis of depression, assessed by observer ratings, (iii) report of relapse at follow-up. RESULTS: We identified 11 studies, 6 of which included a non-psychotherapeutic comparison condition. Together they comprised long-term data of 966 patients. Mean follow-up duration was 4.4 years. The overall relapse rate at long-term follow-up was 0.39 (95% CI 0.29, 0.50). Psychotherapy resulted in significantly less relapses (53.1% vs. 71.1%, OR 0.51; 95% CI 0.32, 0.82, p=0.005) than comparison treatments. This finding corresponded to a number needed to treat (NNT) of 5.55. LIMITATIONS: Results can only be preliminary as data was sparse and studies differed methodologically. Heterogeneity in the first meta-analysis was high (I(2)=82%). Results indicated publication bias. CONCLUSIONS: The relapse rate more than two years after psychotherapy is relatively high, but significantly lower compared to non-psychotherapeutic treatments. Multiannual follow-ups should routinely be included in future psychotherapy RCTs.
Authors: Daniel M Low; Kelly L Zuromski; Daniel Kessler; Satrajit S Ghosh; Matthew Nock; Walter Dempsey Journal: Proc Conf Empir Methods Nat Lang Process Date: 2021-11
Authors: Richard E Daws; Christopher Timmermann; Bruna Giribaldi; James D Sexton; Matthew B Wall; David Erritzoe; Leor Roseman; David Nutt; Robin Carhart-Harris Journal: Nat Med Date: 2022-04-11 Impact factor: 87.241
Authors: Qian Ren; Min Ma; Tamaki Ishima; Christophe Morisseau; Jun Yang; Karen M Wagner; Ji-Chun Zhang; Chun Yang; Wei Yao; Chao Dong; Mei Han; Bruce D Hammock; Kenji Hashimoto Journal: Proc Natl Acad Sci U S A Date: 2016-03-14 Impact factor: 11.205
Authors: Marianne Leuzinger-Bohleber; Martin Hautzinger; Georg Fiedler; Wolfram Keller; Ulrich Bahrke; Lisa Kallenbach; Johannes Kaufhold; Mareike Ernst; Alexa Negele; Margerete Schoett; Helmut Küchenhoff; Felix Günther; Bernhard Rüger; Manfred Beutel Journal: Can J Psychiatry Date: 2018-11-01 Impact factor: 4.356
Authors: Roel J T Mocking; Caroline A Figueroa; Maria M Rive; Hanneke Geugies; Michelle N Servaas; Johanna Assies; Maarten W J Koeter; Frédéric M Vaz; Marieke Wichers; Jan P van Straalen; Rudi de Raedt; Claudi L H Bockting; Catherine J Harmer; Aart H Schene; Henricus G Ruhé Journal: BMJ Open Date: 2016-03-01 Impact factor: 2.692